Journal profile · Pharmacology & Pharmacy
Life Sciences
ISSN 0024-3205 · eISSN 1879-0631 · Elsevier Inc. · ENGLAND · Weekly · Founded 1973
Life Sciences: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6.4; hybrid open access; APC about USD 3,810; median 98 days to acceptance (120 articles, last 24 months); community-reported acceptance: about 62.5%; 656 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Life Sciences is published by Elsevier Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research and Neuropeptides and Animal Physiology, together about 34.1% of its articles. Its main subfields are Cellular and Molecular Neuroscience and Physiology. (generated from OpenAlex topic counts and CAS ranking data)
Browse through a wide range of high-quality academic journals offered by Elsevier, including open access options, to enrich your research journey.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology12.7%
- Neuroscience and Neuropharmacology ResearchNeuroscience10.7%
- Neuropeptides and Animal PhysiologyNeuroscience10.7%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience7.3%
- Nitric Oxide and Endothelin EffectsMedicine5.3%
- Ion channel regulation and functionBiochemistry, Genetics and Molecular Biology5%
- Pain Mechanisms and TreatmentsMedicine4.2%
- Stress Responses and CortisolNeuroscience4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2020 edition (low risk); not listed in the other 5 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.4LetPub ·
- CiteScore 2026-06
- 10.7LetPub ·
- SJR 2026-06
- 1.49LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 150LetPub ·
- h-index
- 288OpenAlex ·
- i10-index
- 24,898OpenAlex ·
- 2-year mean citedness
- 6.51OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 17.97%LetPub ·
Volume
- Articles per year
- 586LetPub ·
Articles by year OpenAlex count · 38,024 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 404 | 96 | 186 |
| 2025 | 656 | 184 | 2,609 |
| 2024 | 782 | 222 | 9,196 |
| 2023 | 854 | 199 | 14,390 |
| 2022 | 887 | 207 | 17,910 |
| 2021 | 1,136 | 214 | 32,652 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
98 daysMedian, submission to acceptance · P25–P75 74 days – 133 days
- Acceptance to online
- median 4 days (120 articles)
- Submission to online
- median 103 days
- Sample
- 120 articles with submission and acceptance dates (1,333 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 62.5%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,810 / EUR 3,560 / GBP 3,050 / JPY 472,550 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Weekly
- Founded
- 1973
- ISSN
- 0024-3205
- Electronic ISSN
- 1879-0631
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Life Sciences
What CAS zone is Life Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Life Sciences is in Zone 3 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Life Sciences?
The latest impact factor listed by LetPub is 6.4; CiteScore 10.7, h-index 288.
How long does peer review take at Life Sciences?
Based on the dates recorded on 120 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 74–133 days); authors report an average review time of about 6 months; the community-reported acceptance is “about 62.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Life Sciences?
According to LetPub and DOAJ records, Life Sciences is indexed in SCIE and Scopus.
Is Life Sciences open access, and what is the APC?
Life Sciences is a hybrid journal. For open-access publication: APC about USD 3,810.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .